2bbb: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:2bbb.gif|left|200px]] | [[Image:2bbb.gif|left|200px]] | ||
<!-- | |||
The line below this paragraph, containing "STRUCTURE_2bbb", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
| | --> | ||
| | {{STRUCTURE_2bbb| PDB=2bbb | SCENE= }} | ||
}} | |||
'''Structure of HIV1 protease and hh1_173_3a complex.''' | '''Structure of HIV1 protease and hh1_173_3a complex.''' | ||
Line 30: | Line 27: | ||
[[Category: Kuo, L C.]] | [[Category: Kuo, L C.]] | ||
[[Category: Munshi, S.]] | [[Category: Munshi, S.]] | ||
[[Category: | [[Category: Hydrolase]] | ||
[[Category: | [[Category: Protease]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 20:04:05 2008'' | |||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on |
Revision as of 20:04, 3 May 2008
Structure of HIV1 protease and hh1_173_3a complex.
OverviewOverview
A series of monopyrrolinone-based HIV-1 protease inhibitors possessing rationally designed P2' side chains have been synthesized and evaluated for activity against wild-type HIV-1 protease. The most potent inhibitor displays subnanomolar potency in vitro for the wild-type HIV-1 protease. Additionally, the monopyrrolinone inhibitors retain potency in cellular assays against clinically significant mutant forms of the virus. X-ray structures of these inhibitors bound in the wild-type enzyme reveal important insights into the observed biological activity.
About this StructureAbout this Structure
2BBB is a Single protein structure of sequence from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.
ReferenceReference
Design, synthesis, and biological evaluation of monopyrrolinone-based HIV-1 protease inhibitors possessing augmented P2' side chains., Smith AB 3rd, Charnley AK, Harada H, Beiger JJ, Cantin LD, Kenesky CS, Hirschmann R, Munshi S, Olsen DB, Stahlhut MW, Schleif WA, Kuo LC, Bioorg Med Chem Lett. 2006 Feb 15;16(4):859-63. Epub 2005 Nov 18. PMID:16298527 Page seeded by OCA on Sat May 3 20:04:05 2008